Connect Biopharma HldgsCNTB
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 11 institutions reported holding Connect Biopharma Hldgs Ltd. (CNTB) in their 13F filings, down 1 from Q2 2024. 1 opened new positions and 3 sold out. The largest holders were BML Capital Management, LLC ($3.0M), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ($725K) and Renaissance Technologies ($253K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Connect Biopharma Hldgs Ltd.
- CUSIP
- 207523101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $60K |
| Exits | 3 | $5K |
All 13F filers, Q2 2024 → Q3 2024: 110,957 shares bought and 40,414 shares sold, net +70,543 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| BML Capital Management, LLC | 1.77% | Add +2.5% | 2,093,232 | $3.0M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | No change | 510,701 | $725K |
| Renaissance Technologies | 0.00% | Reduce -17.3% | 175,500 | $253K |
| Callan Capital, LLC | 0.00% | New | 41,823 | $60K |
| Keudell/Morrison Wealth Management | 0.01% | Add +3.9% | 33,450 | $48K |
| Royal Bank of Canada | 0.00% | Add +140.9% | 30,600 | $44K |
| Geode Capital Management, LLC | 0.00% | No change | 27,961 | $40K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 20,000 | $29K |
| Rhumbline Advisers | 0.00% | No change | 9,500 | $13K |
| BlackRock, Inc. | 0.00% | — | 1,838 | $3K |
| JPMorgan Chase & Co. | 0.00% | No change | 121 | $172 |
"% of holder's portfolio" is CNTB's weight in each manager's 13F, not the share of Connect Biopharma Hldgs Ltd. the manager owns.